Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2001
04/25/2001EP1093455A1 Bis-indole derivatives and their use as antiinflammatory agents
04/25/2001EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
04/25/2001EP1093451A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines
04/25/2001EP1093450A1 Desformoterol and process for its preparation
04/25/2001EP1093383A1 Drug delivery system comprising a homeobox peptide
04/25/2001EP1093381A1 Antigenic peptides derived from telomerase
04/25/2001EP1093379A2 Use of inhibitors of protein kinase c epsilon to treat pain
04/25/2001EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
04/25/2001EP1093371A1 Use of fk506 and related macrolides in the manufacture of a medicament for treatment or prevention of pain
04/25/2001EP1093370A1 Pharmaceutical composition for the treatment of diabetes
04/25/2001EP1093369A2 Agents with an antidepressive effect
04/25/2001EP1093368A1 INDOLE AND TETRAHYDROISOQUINOLINE CONTAINING $g(a)-KETO OXADIAZOLES AS SERINE PROTEASE INHIBITORS
04/25/2001EP1093367A1 Protease inhibitors
04/25/2001EP1093366A1 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles
04/25/2001EP1093365A2 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain
04/25/2001EP1093364A1 A method for stimulation of defensin production by exposure to isoleucin
04/25/2001EP1093363A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
04/25/2001EP1093362A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
04/25/2001EP1093361A1 Plaster which contains steroids, and a method for the production and use thereof
04/25/2001EP1093360A2 Cleansing and treating lotion for treating comedones
04/25/2001EP1093348A1 Methods and transdermal compositions for pain relief
04/25/2001EP1093337A1 Food supplements comprising lipoic acid and creatine and methods for their use
04/25/2001EP1007068A4 Process for preparing synthetic soil-extract materials and medicaments based thereon
04/25/2001EP0994872B1 4-phenylpiperidine compounds
04/25/2001EP0804176B1 Transdermal presentation of nitroglycerin for preventing undesired labour
04/25/2001EP0701568B1 New peptide derivatives
04/25/2001EP0626863B1 Formulations containing hyaluronic acid
04/25/2001CN1292820A i (Neisseria meningitidis) antigens
04/25/2001CN1292797A Cholenic acid amides and pharmaceutical compositions thereof
04/25/2001CN1292795A Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent
04/25/2001CN1292789A 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
04/25/2001CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/25/2001CN1292785A Hypolipidemic benzothiazepine compounds
04/25/2001CN1292783A Method for preparing sulfanyl-type endothelin receptor antagonists
04/25/2001CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists
04/25/2001CN1292781A Antivirals
04/25/2001CN1292779A Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
04/25/2001CN1292707A Anhydrous topical skin preparation
04/25/2001CN1292704A Ginkgo leaves composition and preparation method and uses
04/25/2001CN1292702A Newcontraceptive kit for monotherapy
04/25/2001CN1292701A Glucocorticoid receptor antagonists for treatment of dementia
04/25/2001CN1292700A IgE antibody production inhibitors and autoimmune diseases inhibitors
04/25/2001CN1292699A Method of treating skin irritation
04/25/2001CN1292698A Glycine transport inhibitors
04/25/2001CN1292697A Anti-viral compound
04/25/2001CN1292696A Composition
04/25/2001CN1292695A Use of macrolide compounds for treatment of ARDS
04/25/2001CN1292694A New use
04/25/2001CN1292693A Indole-3-propionic acids, salts and esters thereof used as medicaments
04/25/2001CN1292692A Oral preparations containing forskolin derivatives and process for producing medicinal preparations
04/25/2001CN1292691A Preparation for treatment of erectile dysfunction
04/25/2001CN1292690A Use of alpha-RAR antagonists for inhibition of mucin secretion
04/25/2001CN1292689A Fat emulsions for inhalational administration
04/25/2001CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide
04/25/2001CN1292683A Compositions containing organic compounds
04/25/2001CN1292682A Skin normalizing agents
04/25/2001CN1292378A Trinitrogenazole alcohol antifungal compound and its preparation method
04/25/2001CN1292276A Medicine for curing chicken trachitis
04/25/2001CN1292265A Eye drops and preparation method thereof
04/25/2001CN1292264A Phosphodiesterase inhibitor and its use
04/25/2001CN1292263A New application of taxal anti-tumor medicine
04/25/2001CN1292262A 15-40% acetaminophen solution preparation
04/25/2001CN1064966C Condesned thiazole derivatives, having 5-HT receptor affinity
04/25/2001CN1064965C Novel sulfonamides compound and its use as medicine
04/25/2001CN1064964C Novel benzobiukyl, preparation of same and parmaceutical composition of same
04/25/2001CN1064962C Arylalkyl-thiadiazinones
04/25/2001CN1064959C N-substituted azabicycloheptane derivatives and preparing process and use thereof
04/25/2001CN1064958C Method for preparation of taxol midbody
04/25/2001CN1064956C Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same
04/25/2001CN1064955C Fluorine-containing benzoylguanidines
04/25/2001CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same
04/25/2001CN1064952C New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them
04/25/2001CN1064836C Application of angelic lactone as biological reaction regulator to prepare antitumor medicine
04/25/2001CN1064813C Methylolhydantoins compositions
04/25/2001CA2324116A1 Nk-1 receptor antagonists and eletriptan for the treatment of migraine
04/24/2001US6222062 Beta-ketoester compounds
04/24/2001US6222051 Alpha-tocopherol 4-aminobenzoic acid ester compounds and method for preparing the same
04/24/2001US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain
04/24/2001US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde
04/24/2001US6222034 As serotinin receptor antagonists; for therapy of depression, central nervous system disorders
04/24/2001US6222027 Molecules expressed in hippocampus
04/24/2001US6222025 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
04/24/2001US6222022 Amino acid sequences of protein related to glial-derived neurotrophic factor and neurturin; diagnosis and treatment of alzheimer's/parkinson's/huntington's diseases, strokes, brain and spinal chord injuries, amyotrophic lateral sclerosis
04/24/2001US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies
04/24/2001US6222014 Amino acid sequence of protein from ribonucleotide diphosphate reductase family; drug screening of bactericides and antibiotics
04/24/2001US6221959 Polynucleotide, polymer complex
04/24/2001US6221927 Polar solvent-in-oil emulsions and multiple emulsions
04/24/2001US6221915 Pharmaceutical compositions
04/24/2001US6221913 Dialkyl ureas as calcitonin mimetics
04/24/2001US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject
04/24/2001US6221910 Glutamine containing oral replacement solution
04/24/2001US6221909 Administering to the cow the isopropyl ester of the hydroxy analogue of methionine.
04/24/2001US6221907 Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
04/24/2001US6221906 Anticancer agents
04/24/2001US6221905 Salts of anionic complexes of RU(III), as antimetastatic and antineoplastic agents
04/24/2001US6221904 Administering to the subject an amount of dehydroascorbic acid
04/24/2001US6221903 Amiodarone as an antifungal agent
04/24/2001US6221901 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same
04/24/2001US6221900 Inhibitors of bruton's tyrosine kinase (btk).
04/24/2001US6221899 Rheumatic disorders; antiinflammatory agents; bone disorders